TMCI · NASDAQ
Treace Medical Concepts (TMCI) Stock Price & Fundamentals
Treace Medical Concepts (TMCI) closed at $1,101.92 on Oct 9, 2026, down 0.32% from the previous close of $1,105.44.
Share price, past year
1Y +69.70%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $1,101.92 |
| Sep 30, 2026 | $1,102.27 |
| Aug 31, 2026 | $1,073.06 |
| Jul 31, 2026 | $1,018.02 |
| Jun 30, 2026 | $968.10 |
| May 29, 2026 | $943.92 |
| Apr 30, 2026 | $900.13 |
| Mar 31, 2026 | $869.08 |
| Feb 27, 2026 | $845.85 |
| Jan 30, 2026 | $766.51 |
| Dec 31, 2025 | $758.27 |
| Nov 28, 2025 | $748.48 |
| Oct 31, 2025 | $711.10 |
Key statistics
- Market cap
- $71.66B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.92
- Revenue (TTM)
- $205.31M
- Net income (TTM)
- −$59.52M
- Shares outstanding
- 65M
- Dividend yield
- —
- 52-week range
- $649.33 – $1,132.03
Treace Medical Concepts's market cap is $71.66B, based on a share price of $1,101.92 and 65M shares outstanding as of Jul 31, 2026.
Financials
Treace Medical Concepts reported revenue of $212.69M for fiscal 2025, up 1.59% from fiscal 2024.
Treace Medical Concepts reported a net loss of $59.00M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 7 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $212.69M | +1.6% | −$59.00M | −27.7% | −$0.93 | −$29.49M |
| FY2024ended Dec 31, 2024 | $209.36M | +11.9% | −$55.74M | −26.6% | −$0.90 | −$48.76M |
| FY2023ended Dec 31, 2023 | $187.12M | +31.9% | −$49.53M | −26.5% | −$0.81 | −$46.03M |
| FY2022ended Dec 31, 2022 | $141.84M | +50.2% | −$42.82M | −30.2% | −$0.77 | −$45.49M |
| FY2021ended Dec 31, 2021 | $94.42M | +64.6% | −$20.55M | −21.8% | −$0.43 | −$19.90M |
| FY2020ended Dec 31, 2020 | $57.37M | +45.5% | −$3.67M | −6.4% | −$0.12 | −$5.56M |
| FY2019ended Dec 31, 2019 | $39.42M | — | −$4.27M | −10.8% | −$0.13 | −$8.88M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $45.38M | −$15.87M | −$0.24 |
| Q1 FY2026ended Mar 31, 2026 | $47.20M | −$17.96M | −$0.28 |
| Q4 FY2025ended Dec 31, 2025 | $62.52M | −$9.39M | −$0.14 |
| Q3 FY2025ended Sep 30, 2025 | $50.21M | −$16.29M | −$0.26 |
| Q2 FY2025ended Jun 30, 2025 | $47.39M | −$17.40M | −$0.28 |
| Q1 FY2025ended Mar 31, 2025 | $52.57M | −$15.92M | −$0.25 |
| Q4 FY2024ended Dec 31, 2024 | $68.71M | −$501.00K | −$0.01 |
| Q3 FY2024ended Sep 30, 2024 | $45.09M | −$15.36M | −$0.25 |
Company profile
- Name
- Treace Medical Concepts, Inc.
- Ticker
- TMCI
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 100 Palmetto Park Place, Ponte Vedra, FL 32081
- Incorporated in
- FL
- Fiscal year ends
- December
- SEC CIK
- 0001630627
Recent SEC filings
- Aug 7, 2026
- Aug 7, 2026
- May 20, 2026
- May 8, 2026
- May 8, 2026
- Apr 9, 2026
- Feb 27, 2026
- Feb 27, 2026
Frequently asked questions
What is Treace Medical Concepts's stock price?
Treace Medical Concepts (TMCI) closed at $1,101.92 on Oct 9, 2026, down 0.32% from the previous close of $1,105.44.
What is Treace Medical Concepts's market cap?
Treace Medical Concepts's market cap is $71.66B, based on a share price of $1,101.92 and 65M shares outstanding as of Jul 31, 2026.
How much revenue does Treace Medical Concepts make?
Treace Medical Concepts reported revenue of $212.69M for fiscal 2025, up 1.59% from fiscal 2024.
Does Treace Medical Concepts pay a dividend?
Treace Medical Concepts's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Treace Medical Concepts, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures